Novartis lung drug beneficial in late stage study (Reuters)Reuters - Swiss drugmaker Novartis said a respiratory medicine improved lung function and significantly reduced breathlessness in a late stage trial.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_novartis.html